emocha Mobile Health Inc. (“emocha”) was founded in 2013 to commercialize a mobile health software platform created at Johns Hopkins University (JHU). In 2008, infectious disease clinicians and public health experts at JHU launched their first mobile application in Uganda to monitor HIV patients, and subsequently deployed more than fifteen applications in ten countries around the world. In early 2013, entrepreneur Sebastian Seiguer began due diligence on the technology, and formed a company to license exclusive rights to the platform, retaining the clinician inventors as scientific advisors.
While the platform had been used predominantly for mobile data capture in research studies on infection control, the founders identified a unique opportunity: creating a platform to improve and understand medication adherence and linkage to care. The emocha team has kept growing since. Our origins at JHU have resulted in an advisory board that provides the medical expertise needed for each project. We have applications deployed on five continents, covering diseases and use cases such as: TB, HIV, HCV, outbreak management, dengue fever, Chagas disease, behavioral health, maternal health, diabetes, and hemophilia.